Blandine Lacroix

Blandine Lacroix is a seasoned executive in the pharmaceutical industry, currently serving as Senior Vice President of Strategy & Rare Disease at Novo Nordisk since April 2002. With a focus on long-term strategic planning and business transformation, Blandine has led the Rare Disease Business, generating $1B in revenue while overseeing cross-functional strategies in obesity and diabetes marketing. Prior roles include Corporate Vice President positions for various business units and accomplishments in turnaround strategies, significantly increasing market share for insulin products. Blandine's earlier career includes management roles at Eli Lilly, HCN, and Avery Dennison, along with teaching marketing at Anglo American College. Educational credentials include a Master in International Business Studies from the University of South Carolina and an MBA in International Business from OMNES Education.